Fingolimod Hydrochloride

CD4 molecule ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35288472 Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients. 2022 Apr 1 1
2 33530945 Increased multiple sclerosis disease activity in patients transitioned from fingolimod to dimethyl fumarate: a case series. 2021 Feb 2 1
3 33007647 Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment. 2020 Dec 15 2
4 30122421 Fingolimod modulates T cell phenotype and regulatory T cell plasticity in vivo. 2019 Jan 1
5 30852478 Efficacy of fingolimod combined with alteplase in acute ischemic stroke and rehabilitation nursing. 2019 Jan 1
6 30263146 The effect of disease modifying therapies on CD62L expression in multiple sclerosis. 2018 Jul-Sep 1
7 30537798 Characterization of CD4+ and CD8+ T Cell Subsets and Interferon Regulatory Factor 4 (IRF4) in MS Patients Treated with Fingolimod (FTY-720): A Follow-up Study. 2018 Aug 12 3
8 28155899 Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis. 2017 Feb 3 1
9 27853088 Disseminated Cryptococcosis in a 63-year-old Patient with Multiple Sclerosis Treated with Fingolimod. 2016 1
10 24507619 Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis. 2014 Mar 15 1
11 16393960 Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. 2006 Jan 15 1
12 15814275 Preoperative administration of FTY720 prolonged renal allograft survival. 2005 Mar 1